Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neurons are polarized cells with morphologically and functionally distinct axons and dendrites. The
SAD
kinases are crucial for establishing the axon-dendrite identity across species. Previous studies suggest that a
tumour suppressor
kinase, LKB1, in the presence of a pseudokinase, STRADalpha, initiates axonal differentiation and growth through activating the
SAD
kinases in vertebrate neurons. STRADalpha was implicated in the localization, stabilization and activation of LKB1 in various cell culture studies. Its in vivo functions, however, have not been examined. In our present study, we analyzed the neuronal phenotypes of the first loss-of-function mutants for STRADalpha and examined their genetic interactions with LKB1 and
SAD
in C. elegans. Unexpectedly, only the C. elegans STRADalpha, STRD-1, functions exclusively through the
SAD
kinase,
SAD
-1, to regulate neuronal polarity and synaptic organization. Moreover, STRD-1 tightly associates with
SAD
-1 to coordinate its synaptic localizations. By contrast, the C. elegans LKB1, PAR-4, also functions in an additional genetic pathway independently of
SAD
-1 and STRD-1 to regulate neuronal polarity. We propose that STRD-1 establishes neuronal polarity and organizes synaptic proteins in a complex with the
SAD
-1 kinase. Our findings suggest that instead of a single, linear genetic pathway, STRADalpha and LKB1 regulate neuronal development through multiple effectors that are shared in some cellular contexts but distinct in others.
...
PMID:C. elegans STRADalpha and SAD cooperatively regulate neuronal polarity and synaptic organization. 2002 64
Human S100A2 is an EF-hand protein and acts as a major
tumour suppressor
, binding and activating p53 in a Ca2+-dependent manner. Ca2+-bound S100A2 was crystallized and its structure was determined based on the anomalous scattering provided by six S atoms from methionine residues and four calcium ions present in the asymmetric unit. Although the diffraction data were recorded at a wavelength of 0.90 A, which is usually not assumed to be suitable for calcium/sulfur
SAD
, the anomalous signal was satisfactory. A nine-atom substructure was determined at 1.8 A resolution using SHELXD, and SHELXE was used for density modification and phase extension to 1.3 A resolution. The electron-density map obtained was well interpretable and could be used for automated model building by ARP/wARP.
...
PMID:Crystallization and calcium/sulfur SAD phasing of the human EF-hand protein S100A2. 2082 19